TLR7 Agonist-Loaded Gadolinium Oxide Nanotubes Promote Anti-Tumor Immunity by Activation of Innate and Adaptive Immune Responses

被引:2
作者
Wang, Xiupeng [1 ]
Hirose, Motohiro [1 ]
Li, Xia [1 ,2 ]
机构
[1] Natl Inst Adv Ind Sci & Technol, Hlth & Med Res Inst, Dept Life Sci & Biotechnol, Cent 6,1-1-1 Higashi, Tsukuba 3058566, Japan
[2] Natl Inst Mat Sci NIMS, 1-1 Namiki, Tsukuba 3050044, Japan
关键词
Gd2O3; nanotubes; adjuvant; cancer; immunotherapy; DENDRITIC CELLS; VACCINES; NANOPARTICLES; ADJUVANTS; ANALOGS; SILICA; RNA;
D O I
10.3390/vaccines12040373
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Improving the delivery of biomolecules to DCs and lymph nodes is critical to increasing their anti-tumor efficacy, reducing their off-target side effects, and improving their safety. In this study, Gd2O3 nanotubes with lengths of 70-80 nm, diameters of 20-30 nm, and pore sizes of up to 18 nm were synthesized using a facile one-pot solvothermal method. The Gd2O3 nanotubes showed good adsorption capacity of OVA and TLR7a, with a loading efficiency of about 100%. The Gd2O3 nanotubes showed pH-sensitive degradation and biomolecule release properties; the release of gadolinium ions, OVA, and TLR7a was slow at pH 7.4 and fast at pH 5. The Gd2O3 nanotubes showed 2.6-6.0 times higher payload retention around the injection site, 3.1 times higher cellular uptake, 1.7 times higher IL1 beta secretion, 1.4 times higher TNF alpha secretion by BMDCs, and markedly enhanced draining lymph node delivery properties. The combination of OVA, TLR7a, and Gd2O3 nanotubes significantly inhibited tumor growth and increased survival rate compared with only OVA-TLR7a, only OVA, and saline. The Gd2O3 nanotubes are biocompatible and can also be used as radiation sensitizers.
引用
收藏
页数:13
相关论文
共 44 条
[1]  
Balachandran VP, 2022, J CLIN ONCOL, V40
[2]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[3]   Enhancement of tumor necrosis factor a antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13) [J].
Curnis, F ;
Sacchi, A ;
Borgna, L ;
Magni, F ;
Gasparri, A ;
Corti, A .
NATURE BIOTECHNOLOGY, 2000, 18 (11) :1185-1190
[4]   Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose [J].
de Titta, Alexandre ;
Ballester, Marie ;
Julier, Ziad ;
Nembrini, Chiara ;
Jeanbart, Laura ;
van der Vlies, Andre J. ;
Swartz, Melody A. ;
Hubbell, Jeffrey A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (49) :19902-19907
[5]   Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma [J].
Elmusrati, Areeg ;
Wang, Justin ;
Wang, Cun-Yu .
INTERNATIONAL JOURNAL OF ORAL SCIENCE, 2021, 13 (01)
[6]   Interferon-γ: teammate or opponent in the tumour microenvironment? [J].
Gocher, Angela M. ;
Workman, Creg J. ;
Vignali, Dario A. A. .
NATURE REVIEWS IMMUNOLOGY, 2022, 22 (03) :158-172
[7]   Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway [J].
Hemmi, H ;
Kaisho, T ;
Takeuchi, O ;
Sato, S ;
Sanjo, H ;
Hoshino, K ;
Horiuchi, T ;
Tomizawa, H ;
Takeda, K ;
Akira, S .
NATURE IMMUNOLOGY, 2002, 3 (02) :196-200
[8]  
Irvine DJ, 2013, NAT MATER, V12, P978, DOI [10.1038/NMAT3775, 10.1038/nmat3775]
[9]   Toll-like receptor control of the adaptive immune responses [J].
Iwasaki, A ;
Medzhitov, R .
NATURE IMMUNOLOGY, 2004, 5 (10) :987-995
[10]   In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles [J].
Jewell, Christopher M. ;
Lopez, Sandra C. Bustamante ;
Irvine, Darrell J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (38) :15745-15750